Präsentation
Filtern
Erscheinungsjahr
- 2017 (4) (entfernen)
Dokumenttyp
- Vortrag (2)
- Posterpräsentation (2)
Referierte Publikation
- nein (4)
Schlagworte
- ELISA (4) (entfernen)
Eingeladener Vortrag
- nein (2)
Bisphenol A (BPA) is a common industrial chemical that is widely used as a monomer or additive in the production of polymer materials. This substance causes impairment of the childbearing function, acceleration of sexual aging, negatively impacts the brain, and also contributes to the development of certain oncological diseases, as well as increasing the risk of a fetus developing the Down syndrome. But the biggest downside of bisphenol is the fact that it accumulates in the system during its use, as well as after. Many methods have been proposed for the determination of BPA, in particular, gas and liquid chromatography. The main disadvantages of such approaches are the high cost of the equipment, the significant duration of an analysis, and difficulties in screening a large number of samples. Immunoanalytical techniques attributes are high throughput, high specificity and sensitivity, as well as low cost and simplicity. Particularly interesting as a quick test for screenings is the lateral flow immunoassay (LFIA), a format widely in use for the detection of pregnancy. LFIA for BPA have been described before, but lack sensitivity.
In this work, focuses on the conjugation (by passive adsorption) efficiency of the different monoclonal antibodies with 40 nm gold nanoparticles. The effect of factors such as pH value and concentration of antibody has been quantificationally discussed using spectra methods after adding 10% NaCl which induced gold nanoparticle aggregation. Consequently, 40 nm gold nanoparticles should be labeled with antibody under optimal pH value and optimal concentrations of antibody. It will be helpful for the application of antibody-labeled gold nanoparticles for the determination of bisphenol A in aqueous solutions (water from different sources, leachates and extracts).
The Short Course “Immunoanalytical Methods for Environmental, Food and Clinical Analysis” offers training in antibody-based analytical techniques. The course is suitable also for beginners. The Short Course comprises Lecture Units teaching the concepts, equipment, reagents and explains the protocols to be used in the practical part. Simple “Hands On” units are offered employing portable instrumentation. – The Short Course spans from antigen production, generation of antibodies, assay development and optimization, data evaluation to the different formats that have been developed. Examples are provided from the areas of environmental analysis (pharmaceuticals, hormones and anthropogenic markers in water and wastewater), food analysis (caffeine in beverages, mycotoxins) and clinical diagnostics (infarction biomarkers). The attendants will be enabled to select an appropriate method and to judge its applicability for their given analytical problem.
Bisphenol A (BPA) is a common industrial chemical that is widely used as a monomer or additive in the production of polycarbonate plastics and other polymeric materials. The primary way of exposure to BPA for most people is assumed to be a direct con-tamination of food and water through use of containers, bottles, and other plastic stor-age. BPA has been identified as an important endocrine disrupting compound (EDC). It can interfere with hormonal activities like biosynthesis, metabolism and elimination of natural blood-borne hormones. Moreover, BPA can originate environmental problems. A spectrum of methods have been developed with the aim of determining BPA in water. Immunoassays appear to comply with sensitivity, rapidity, and low cost requirements for effective monitoring.
In this work a comparative analysis was conducted of the effect of temperature and the choice of buffers, as well as the substrate at various stages of an ELISA (enzyme-linked immunosorbent assay). The method has been optimized and has shown good repeatability and sensitivity. The results obtained from ELISA will be used as the basis for the development of a Lateral Flow ImmunoAssay (LFIA).